J&J says analysis demonstrates potential of Tecvayli-Darzalex combo for multiple myeloma

Summary

Johnson & Johnson announced analysis results demonstrating the potential of a Tecvayli and Darzalex combination for treating multiple myeloma. The announcement provides preliminary evidence of the combination therapy's efficacy.